Flinders University Flinders Academic Commons
 

Flinders Academic Commons >
Research Publications >
ERA 2010 >
07 - Biomedical and Clinical Research >
1103 - Clinical Sciences >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2328/10569

Title: Pharmaceutical benefits scheme criteria for the use of tumour necrosis factor-alpha inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?
Authors: Smith, Malcolm Douglas
Ahern, Michael John
Issue Date: 2006
Citation: Smith, M.D. & Ahern, M.J., 2006. Pharmaceutical benefits scheme criteria for the use of tumour necrosis factor-alpha inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?. Internal Medicine Journal, 36(2), 72-76.
URI: http://hdl.handle.net/2328/10569
ISSN: 1444-0903
Appears in Collections:1103 - Clinical Sciences

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback